OBR Green Articles (ASH Conference Coverage)

article

January 2019Edition

Will the second generation of CAR-T therapies eventually supplant first-generation pioneers? Taking our cue from some of the positive data we saw at ASH on first- and second-generation CAR-Ts, and newcomers like Amgen’s AMG 420 BiTE, we investigat...

article

January 2019Edition

At ASH 2018, a myriad of CAR-T presentations demonstrated that the race is on to improve on an already good thing. Some of those approaches included fine-tuning CAR-T design to lessen toxicity, add-ons to CAR-Ts with ibrutinib and checkpoint inhibito...

article

January 2019Edition

A special interest session on social media is now an annual event during ASH. This year, panelists shared with their colleagues how they used social media platforms like Twitter to educate and counter medical misinformation, to help them in recruitin...